Cargando…

Delineating the mechanism of anti-Lassa virus GPC-A neutralizing antibodies

Lassa virus (LASV) is the etiologic agent of Lassa Fever, a hemorrhagic disease that is endemic to West Africa. During LASV infection, LASV glycoprotein (GP) engages with multiple host receptors for cell entry. Neutralizing antibodies against GP are rare and principally target quaternary epitopes di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Enriquez, Adrian S., Buck, Tierra K., Li, Haoyang, Norris, Michael J., Moon-Walker, Alex, Zandonatti, Michelle A., Harkins, Stephanie S., Robinson, James E., Branco, Luis M., Garry, Robert F., Saphire, Erica Ollmann, Hastie, Kathryn M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258627/ https://www.ncbi.nlm.nih.gov/pubmed/35613585 http://dx.doi.org/10.1016/j.celrep.2022.110841

Ejemplares similares

Neutralizing Antibodies against Lassa Virus Lineage I
por: Buck, Tierra K., et al.
Publicado: (2022)

Structural Basis for the dsRNA Specificity of the Lassa Virus NP Exonuclease
por: Hastie, Kathryn M., et al.
Publicado: (2012)

Lassa virus glycoprotein: stopping a moving target
por: Hastie, Kathryn M, et al.
Publicado: (2018)

Potent Omicron-neutralizing antibodies isolated from a patient vaccinated 6 months before Omicron emergence
por: Hastie, Kathryn M., et al.
Publicado: (2023)

Crystal structure of the prefusion surface glycoprotein of the prototypic arenavirus LCMV
por: Hastie, Kathryn M., et al.
Publicado: (2016)

Novel attempts launched toward universal Sarbecovirus vaccine
por: Li, Haoyang, et al.
Publicado: (2021)

Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits
por: Robinson, James E., et al.
Publicado: (2016)

Hiding the evidence: two strategies for innate immune evasion by hemorrhagic fever viruses
por: Hastie, Kathryn M, et al.
Publicado: (2012)

Antibodies to the Glycoprotein GP2 Subunit Cross-React between Old and New World Arenaviruses
por: Amanat, Fatima, et al.
Publicado: (2018)

Structure of the rabies virus glycoprotein trimer bound to a prefusion-specific neutralizing antibody
por: Callaway, Heather M., et al.
Publicado: (2022)

Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever
por: Boisen, Matthew L., et al.
Publicado: (2018)

Lassa Fever in Post-Conflict Sierra Leone
por: Shaffer, Jeffrey G., et al.
Publicado: (2014)

A Lassa virus mRNA vaccine confers protection but does not require neutralizing antibody in a guinea pig model of infection
por: Ronk, Adam J., et al.
Publicado: (2023)

Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages
por: Heinrich, Megan L., et al.
Publicado: (2020)

Proximity interactome analysis of Lassa polymerase reveals eRF3a/GSPT1 as a druggable target for host-directed antivirals
por: Fang, Jingru, et al.
Publicado: (2022)

Detection of Lassa Virus, Mali
por: Safronetz, David, et al.
Publicado: (2010)

Characterization of the Lassa virus GP1 ectodomain shedding: implications for improved diagnostic platforms
por: Branco, Luis M, et al.
Publicado: (2009)

Development and Structural Analysis of Antibody Therapeutics for Filoviruses
por: Yu, Xiaoying, et al.
Publicado: (2022)

CD164 is a host factor for lymphocytic choriomeningitis virus entry
por: Bakkers, Mark J. G., et al.
Publicado: (2022)

Lassa fever — the road ahead
por: Garry, Robert F.
Publicado: (2022)

Elevated l-threonine is a biomarker for Lassa fever and Ebola
por: Gale, Trevor V., et al.
Publicado: (2020)

Lifted Up from Lockdown
por: Arturo, Emilia C., et al.
Publicado: (2020)

Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever
por: Abreu-Mota, Tiago, et al.
Publicado: (2018)

Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever
por: Branco, Luis M, et al.
Publicado: (2010)

Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodies
por: Perrett, Hailee R., et al.
Publicado: (2023)

Pathogenesis of Lassa Fever
por: Yun, Nadezhda E., et al.
Publicado: (2012)

Plasmodium infection disrupts the T follicular helper cell response to heterologous immunization
por: Fontana, Mary F, et al.
Publicado: (2023)

Structural Basis of Pan-Ebolavirus Neutralization by a Human Antibody against a Conserved, yet Cryptic Epitope
por: West, Brandyn R., et al.
Publicado: (2018)

Data set on Lassa fever in post-conflict Sierra Leone
por: Shaffer, Jeffrey G., et al.
Publicado: (2019)

Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection
por: Brouwer, Philip J.M., et al.
Publicado: (2022)

Structural Basis for Differential Neutralization of Ebolaviruses
por: Bale, Shridhar, et al.
Publicado: (2012)

SARS-CoV-2 antibodies specific to the mesa and inner side of spike protein receptor binding domain maintain high affinities for both D614G and b.1.351 variants
por: Li, Kan, et al.
Publicado: (2022)

Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies
por: Bornholdt, Zachary A., et al.
Publicado: (2016)

Sudan Ebolavirus VP35-NP Crystal Structure Reveals a Potential Target for Pan-Filovirus Treatment
por: Landeras-Bueno, Sara, et al.
Publicado: (2019)

SnapShot: Enveloped Virus Entry
por: Mercer, Jason, et al.
Publicado: (2020)

Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection
por: Branco, Luis M, et al.
Publicado: (2011)

Marburg Virus VP35 Can Both Fully Coat the Backbone and Cap the Ends of dsRNA for Interferon Antagonism
por: Bale, Shridhar, et al.
Publicado: (2012)

Measles and Nipah virus assembly: Specific lipid binding drives matrix polymerization
por: Norris, Michael J., et al.
Publicado: (2022)

Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects
por: Branco, Luis M, et al.
Publicado: (2010)

Geographic Distribution and Genetic Characterization of Lassa Virus in Sub-Saharan Mali
por: Safronetz, David, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gitddk5ij0q5jbpukm99v56ap6